Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Study of Heart and Renal Protection
2004-001156-37Phase 3Completed
- Sponsor
- University of Oxford
- Start
- Jul 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of ezetimibe and simvastatin in chronic kidney disease (CKD) (2 arms), sponsored by University of Oxford. Primary endpoint: Time to first major vascular event. Started Jul 2005; status: completed.
02
Drugs
ezetimibesimvastatin
03
Conditions
chronic kidney disease (CKD)
Beyond the preview
Go deeper on 2004-001156-37.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-001156-37.